Always consult your healthcare provider before beginning any new supplement
[45] Advertisement References About This Article Thanks to all authors for creating a page that has been read 32,719 times
A Phase III, Randomised, Double Blind, Placebo Controlled, Parallel Group Study, to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide (16 mg) in Patients Suffering From Polymorphic Light Eruption (PLE) (Report)
Taiwan Patent Application TW201620396 (A) Nie M, Wei G, Shao N, Ge X (2010) A novel strategy on the high-cell-density cultivation of Candida utilis for the enhanced production of glutathione
Alesci S, De Martino MU, Kino T, Ilias I